Ki-67 proliferative index in gastroenteropancreatic neuroendocrine neoplasms

Research output: Contribution to journalArticle

Abstract

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are potentially malignant neoplasms that differ significantly in their clinical behavior and metastatic potential according to several factors. Among these factors, Ki-67 proliferative index (PI) is a crucial element in determining the World Health Organization (WHO) grade of GEP-NENs, which is in itself a major cornerstone in determining patient prognosis and guiding treatment. In this article, we report a case of a pancreatic neuroendocrine tumor demonstrating a characteristic slowly progressive course and eventually resulting in patient death. We utilize immunohisto-chemical staining for Ki-67 to determine the tumor's PI and classify it according to the 2010 WHO grading system. We then review the prognostic value of Ki-67 and its role in the current WHO classification of GEP-NENs, discuss the best methods of determining a tumor's PI based on Ki-67 immunohistochemistry, and address a few problematic issues in the current WHO grading scheme. We stress that Ki-67 PI should be estimated based on the hotspot technique, utilizing either conventional manual count or digital imaging analysis, but eyeball estimates should be avoided. Although the current WHO grading scheme provides good prognostic stratification, we suggest that it may require some future refinement in order to provide more site-specific categorization and include certain categories that are not well addressed in the current scheme.

Original languageEnglish (US)
Pages (from-to)256-260
Number of pages5
JournalPathology Case Reviews
Volume19
Issue number5
DOIs
StatePublished - Dec 10 2014

Fingerprint

Neoplasms
Neuroendocrine Tumors
Immunohistochemistry
Staining and Labeling
Therapeutics

Keywords

  • Ki-67
  • MIB-1
  • Neuroendocrine neoplasms
  • Proliferative index

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Ki-67 proliferative index in gastroenteropancreatic neuroendocrine neoplasms. / Mounajjed, Taofic; Henry, Michael; Zhang, Lizhi.

In: Pathology Case Reviews, Vol. 19, No. 5, 10.12.2014, p. 256-260.

Research output: Contribution to journalArticle

@article{81f897d1a3d94aa198339515e9873096,
title = "Ki-67 proliferative index in gastroenteropancreatic neuroendocrine neoplasms",
abstract = "Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are potentially malignant neoplasms that differ significantly in their clinical behavior and metastatic potential according to several factors. Among these factors, Ki-67 proliferative index (PI) is a crucial element in determining the World Health Organization (WHO) grade of GEP-NENs, which is in itself a major cornerstone in determining patient prognosis and guiding treatment. In this article, we report a case of a pancreatic neuroendocrine tumor demonstrating a characteristic slowly progressive course and eventually resulting in patient death. We utilize immunohisto-chemical staining for Ki-67 to determine the tumor's PI and classify it according to the 2010 WHO grading system. We then review the prognostic value of Ki-67 and its role in the current WHO classification of GEP-NENs, discuss the best methods of determining a tumor's PI based on Ki-67 immunohistochemistry, and address a few problematic issues in the current WHO grading scheme. We stress that Ki-67 PI should be estimated based on the hotspot technique, utilizing either conventional manual count or digital imaging analysis, but eyeball estimates should be avoided. Although the current WHO grading scheme provides good prognostic stratification, we suggest that it may require some future refinement in order to provide more site-specific categorization and include certain categories that are not well addressed in the current scheme.",
keywords = "Ki-67, MIB-1, Neuroendocrine neoplasms, Proliferative index",
author = "Taofic Mounajjed and Michael Henry and Lizhi Zhang",
year = "2014",
month = "12",
day = "10",
doi = "10.1097/PCR.0000000000000054",
language = "English (US)",
volume = "19",
pages = "256--260",
journal = "Pathology Case Reviews",
issn = "1082-9784",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Ki-67 proliferative index in gastroenteropancreatic neuroendocrine neoplasms

AU - Mounajjed, Taofic

AU - Henry, Michael

AU - Zhang, Lizhi

PY - 2014/12/10

Y1 - 2014/12/10

N2 - Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are potentially malignant neoplasms that differ significantly in their clinical behavior and metastatic potential according to several factors. Among these factors, Ki-67 proliferative index (PI) is a crucial element in determining the World Health Organization (WHO) grade of GEP-NENs, which is in itself a major cornerstone in determining patient prognosis and guiding treatment. In this article, we report a case of a pancreatic neuroendocrine tumor demonstrating a characteristic slowly progressive course and eventually resulting in patient death. We utilize immunohisto-chemical staining for Ki-67 to determine the tumor's PI and classify it according to the 2010 WHO grading system. We then review the prognostic value of Ki-67 and its role in the current WHO classification of GEP-NENs, discuss the best methods of determining a tumor's PI based on Ki-67 immunohistochemistry, and address a few problematic issues in the current WHO grading scheme. We stress that Ki-67 PI should be estimated based on the hotspot technique, utilizing either conventional manual count or digital imaging analysis, but eyeball estimates should be avoided. Although the current WHO grading scheme provides good prognostic stratification, we suggest that it may require some future refinement in order to provide more site-specific categorization and include certain categories that are not well addressed in the current scheme.

AB - Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are potentially malignant neoplasms that differ significantly in their clinical behavior and metastatic potential according to several factors. Among these factors, Ki-67 proliferative index (PI) is a crucial element in determining the World Health Organization (WHO) grade of GEP-NENs, which is in itself a major cornerstone in determining patient prognosis and guiding treatment. In this article, we report a case of a pancreatic neuroendocrine tumor demonstrating a characteristic slowly progressive course and eventually resulting in patient death. We utilize immunohisto-chemical staining for Ki-67 to determine the tumor's PI and classify it according to the 2010 WHO grading system. We then review the prognostic value of Ki-67 and its role in the current WHO classification of GEP-NENs, discuss the best methods of determining a tumor's PI based on Ki-67 immunohistochemistry, and address a few problematic issues in the current WHO grading scheme. We stress that Ki-67 PI should be estimated based on the hotspot technique, utilizing either conventional manual count or digital imaging analysis, but eyeball estimates should be avoided. Although the current WHO grading scheme provides good prognostic stratification, we suggest that it may require some future refinement in order to provide more site-specific categorization and include certain categories that are not well addressed in the current scheme.

KW - Ki-67

KW - MIB-1

KW - Neuroendocrine neoplasms

KW - Proliferative index

UR - http://www.scopus.com/inward/record.url?scp=84916637199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916637199&partnerID=8YFLogxK

U2 - 10.1097/PCR.0000000000000054

DO - 10.1097/PCR.0000000000000054

M3 - Article

AN - SCOPUS:84916637199

VL - 19

SP - 256

EP - 260

JO - Pathology Case Reviews

JF - Pathology Case Reviews

SN - 1082-9784

IS - 5

ER -